2,800,000 Shares
Smithtown Bancorp, Inc.
Common Stock
par value $0.01 per share
Underwriting Agreement
May 14, 2009
Sandler
O’Neill & Partners, L.P.,
919 Third
Avenue
6
th Floor
New York, New
York 10022
Ladies and
Gentlemen:
Smithtown Bancorp, Inc., a New York corporation
(the “Company”), proposes, subject to the terms and
conditions stated herein, to issue and sell to Sandler
O’Neill & Partners, L.P. (the “Underwriter”)
an aggregate of 2,800,000 shares (the “Firm Shares”)
and, at the election of the Underwriter, up to 200,000 additional
shares (the “Optional Shares”) of the common stock, par
value $0.01 per share (“Stock”), of the Company (the
Firm Shares and the Optional Shares that the Underwriter elects to
purchase pursuant to Section 2 hereof being collectively called the
“Shares”).
The Company has filed with the Securities and
Exchange Commission (the “Commission”) a registration
statement on Form S-3 (No. 333-153897) covering the registration of
the Shares under the Securities Act of 1933, as amended (the
“Act”), including a related prospectus, which has
become effective. The registration statement (including the
exhibits thereto and schedules thereto, if any) as amended at the
time it became effective, or, if a post-effective amendment has
been filed with respect thereto, as amended by such post-effective
amendment at the time of its effectiveness (including in each case
the information (if any) deemed to be part of such registration
statement at the time of effectiveness pursuant to Rule 430A under
the Act), is hereinafter referred to as the “Registration
Statement.” The term “Effective Date”
shall mean each date that the Registration Statement and any
post-effective amendment or amendments thereto became or become
effective. The term “Base Prospectus” shall
mean the prospectus referred to in Section 1(a)(i) hereof contained
in the Registration Statement at the Effective
Date. “Preliminary Prospectus” means any
preliminary prospectus supplement to the Base Prospectus used prior
to the filing of the Prospectus, together with the Base Prospectus;
the term “Prospectus” means the final prospectus
supplement to the Base Prospectus first filed with the Commission
pursuant to Rule 424(b) under the Act, together with the Base
Prospectus. Any registration statement filed pursuant to
Rule 462(b) under the Act is herein referred to as the “Rule
462(b) Registration Statement,” and after such filing the
term “Registration Statement” shall include the Rule
462(b) Registration Statement.
Any reference in this Agreement to the
Registration Statement, any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3
under the Act, as of the Effective Date or the date of such
Preliminary Prospectus or the Prospectus, as the case may be (it
being understood that the several specific references in this
Agreement to documents incorporated by reference in the
Registration Statement or the Prospectus are for clarifying
purposes only and are not meant to limit the inclusiveness of any
other definition herein). For purposes of this
Agreement, all references to the Registration Statement, any
Preliminary Prospectus, or the Prospectus or any amendment or
supplement to any of the foregoing shall be deemed to include the
copy filed with the Commission pursuant to its Electronic Data
Gathering, Analysis and Retrieval system
(“EDGAR”).
All references in this Agreement to financial
statements and schedules and other information which is
“contained,” “included” or
“stated” in the Registration Statement, any Preliminary
Prospectus or the Prospectus (or other references of like import)
shall be deemed to mean and include all such financial statements
and schedules and other information which is incorporated by
reference in the Registration Statement, any Preliminary Prospectus
or the Prospectus, as the case may be.
1. (a) The
Company represents and warrants to, and agrees with, the
Underwriter that:
(i)
The Company satisfies the registrant
eligibility requirements for the use of Form S-3 under the Act set
forth in General Instruction I.A to such Form and the transactions
contemplated by this Agreement satisfy the transaction eligibility
requirements for the use of such Form set forth in General
Instruction I.B.1 to such Form; the Company has filed with the
Commission the Registration Statement on such Form, including a
Base Prospectus, for registration under the Act of the offering and
sale of the Shares, and the Company may have filed with the
Commission one or more amendments to such Registration Statement,
each in the form previously delivered to you. Such
Registration Statement, as so amended, has been declared effective
by the Commission, and the Shares have been registered under the
Registration Statement in compliance with the requirements for the
use of Form S-3. Although the Base Prospectus may not
include all the information with respect to the Shares and the
offering thereof required by the Act and the rules and regulations
of the Commission thereunder to be included in the Prospectus, the
Base Prospectus includes all such information required by the Act
and the rules and regulations of the Commission thereunder to be
included therein as of the Effective Date. The Company
has complied to the Commission’s satisfaction with all
requests of the Commission for additional or supplemental
information; and no stop order suspending the effectiveness of the
Registration Statement has been issued and no proceeding for that
purpose has been initiated or, to the knowledge of the Company,
threatened by the Commission. After the execution of
this Agreement, the Company will file with the Commission pursuant
to Rules 415 and 424(b)(2) or (5) a final supplement to the Base
Prospectus included in such Registration Statement relating to the
Shares and the offering thereof, with such information as is
required or permitted by the Act and as has been provided to and
approved by the Underwriter prior to the date hereof or, to the
extent not completed at the date hereof, containing only such
specific additional information and other changes (beyond that
contained in the Base Prospectus and any Preliminary Prospectus) as
the Company has advised you, prior to the date hereof, will be
included or made therein. If the Company has elected to
rely on Rule 462(b) and the Rule 462(b) Registration Statement is
not effective, (x) the Company will file a Rule 462(b) Registration
Statement in compliance with, and that is effective upon filing
pursuant to, Rule 462(b) and (y) the Company has given irrevocable
instructions for transmission of the applicable filing fee in
connection with the filing of the Rule 462(b) Registration
Statement, in compliance with Rule 111 under the Act, or the
Commission has received payment of such filing fee.
(ii) No
order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary
Prospectus, at the time of filing thereof, conformed in all
material respects to the requirements of the Act and the rules and
regulations of the Commission thereunder and did not contain an
untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided , however ,
that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity
with information furnished in writing to the Company by the
Underwriter expressly for use therein; there are no contracts or
other documents required to be described in the Prospectus or to be
filed as exhibits to the Registration Statement which have not been
described or filed as required;
As used in this subsection and elsewhere in this
Agreement:
“Applicable Time” means 7:00 p.m.
(Eastern Time) on May 14, 2009.
“General Disclosure Package” means
(i) the Preliminary Prospectus, if any, used most recently prior to
the Time of Delivery, (ii) the Issuer-Represented Free Writing
Prospectuses, if any, identified in Schedule I hereto and
(iii) any other Free Writing Prospectus that the parties hereto
shall hereafter expressly agree in writing to treat as part of the
General Disclosure Package.
“Issuer-Represented Free Writing
Prospectus” means any “issuer free writing
prospectus,” as defined in Rule 433 of the 1933 Act
Regulations (“Rule 433”), relating to the Shares that
(i) is required to be filed with the Commission by the Company or
(ii) is exempt from filing pursuant to Rule 433(d)(5)(i) because it
contains a description of the Shares or of the offering that does
not reflect the final terms, in each case in the form filed or
required to be filed with the Commission or, if not required to be
filed, in the form retained in the Company’s records pursuant
to Rule 433(g).
Each Issuer-Represented Free Writing Prospectus,
when considered together with the General Disclosure Package as of
the Applicable Time, did not contain any untrue statement of
material fact or omit to state a material fact necessary to make
the statements therein, in light of the circumstances in which they
were made, not misleading and, did not, does not and will not
include any information that conflicted, conflicts or will conflict
with the information contained in the Registration Statement or the
Prospectus, including any document incorporated by reference
therein and any preliminary or other prospectus deemed to be a part
thereof that, in each case, has not been superseded or
modified.
(iii) The
Preliminary Prospectus, the Prospectus and each Issuer-Represented
Free Writing Prospectus when filed, if filed by electronic
transmission, pursuant to EDGAR (except as may be permitted by
Regulation S-T under the Act), was identical to the copy thereof
delivered to the Underwriter for use in connection with the offer
and sale of the Shares; the Registration Statement conforms, and
the Prospectus and any further amendments or supplements to the
Registration Statement or the Prospectus will conform, in all
material respects to the requirements of the Act and the rules and
regulations of the Commission thereunder and do not and will not,
as of the Effective Date, and as of the applicable filing date as
to the Prospectus and any amendment or supplement thereto, contain
an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein in light of the circumstances in which they were
made not misleading; provided , however , that this
representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information
furnished in writing to the Company by the Underwriter expressly
for use therein;
(iv) The
documents which are incorporated or deemed to be incorporated by
reference in the Registration Statement or any Preliminary
Prospectus or the Prospectus or from which information is so
incorporated by reference (the “Exchange Acts
Reports”), when they became effective or were filed with the
Commission, as the case may be (or, if an amendment with respect to
any such documents was filed or became effective, when such
amendment was filed or became effective), complied in all material
respects to the requirements of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), and the rules
and regulations of the Commission thereunder, and, when read
together with the other information in the Prospectus, at the time
the Registration Statement became effective, at the Applicable Time
and at any Time of Delivery (as defined below) did not and will not
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make to
the statements therein in light of the circumstances in which they
were made not misleading;
(v)
The financial statements, including the
related schedules and notes, filed with the Commission as a part of
the Registration Statement and included in the Preliminary
Prospectus and the Prospectus (the “Financial
Statements”) present fairly the consolidated financial
position of the Company and its subsidiaries as of and at the dates
indicated and the results of their operations and cash flows for
the periods specified; such Financial Statements, unless otherwise
noted therein have been prepared in conformity with accounting
principles generally accepted in the United States
(“GAAP”) applied on a consistent basis throughout the
periods involved; no other financial statements or supporting
schedules are required to be included in the Registration
Statement, the Preliminary Prospectus and the Prospectus; the
income statement data, balance sheet data and earnings per share
data for the five fiscal years ended December 31, 2008 as set forth
in the Prospectus under the captions “Summary Consolidated
Financial Data” fairly present the information therein on a
basis consistent with that of the audited financial statements
contained in the Registration Statement, the Preliminary Prospectus
and the Prospectus; the income statement data and earnings per
share data for the fiscal quarter ended March 31, 2009 and balance
sheet data as of March 31, 2009 as set forth in the Prospectus
under the caption “Summary Consolidated Financial Data”
fairly present the information therein on a basis consistent with
that of the unaudited financial statements contained in the
Registration Statement; to the extent applicable, all disclosures
contained in the Prospectus regarding “non-GAAP financial
measures” as such term is defined by the rules and
regulations of the Commission comply with Regulation G of the
Exchange Act, the rules and regulations promulgated by the
Commission thereunder and Item 10 of Regulation S-K under the
Act;
(vi) Crowe
Horwath LLP, the independent registered public accounting firm that
certified the financial statements of the Company and its
subsidiaries, that are included in or incorporated by reference
into the Registration Statement and the Prospectus is an
independent registered public accounting firm as required by the
Act and the rules and regulations of the Commission thereunder, and
such accountants are not in violation of the auditor independence
requirements of the Sarbanes-Oxley Act of 2002 (the
“Sarbanes-Oxley Act”) and the related rules and
regulations of the Commission;
(vii) The
statistical and market related data contained in the Prospectus and
Registration Statement are based on or derived from sources which
the Company believes are reliable and accurate;
(viii) This
Agreement has been duly authorized, executed and delivered by the
Company and, when duly executed by the Underwriter, will constitute
the valid and binding agreement of the Company enforceable against
the Company in accordance with its terms, except as enforcement
thereof may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to or affecting
creditors’ rights generally or by general equitable
principles and except as any indemnification or contribution
provisions thereof may be limited under applicable securities
laws;
(ix)
Neither the Company nor any of its
subsidiaries has sustained, since the date of the latest audited
financial statements included in the Registration Statement and the
Prospectus, any material loss or interference with its business
from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor dispute or court or
governmental action, order or decree, otherwise than as set forth
or contemplated in the Prospectus; and, since the respective dates
as of which information is given in the Registration Statement and
the Prospectus, there has not been any material change in the
capital stock or long-term debt of the Company or any of its
subsidiaries or any material adverse change, or any development
that may cause a prospective material adverse change, in or
affecting the general affairs, management, earnings, business,
properties, assets, current or future consolidated financial
position, business prospects, stockholders’ equity or results
of operations of the Company and its subsidiaries considered as one
enterprise, whether or not arising in the ordinary course of
business and there has been no effect with respect to the Company
and its subsidiaries considered as one enterprise, which would
prevent, or be reasonably likely to prevent, the Company from
consummating the transaction contemplated by this Agreement (a
“Material Adverse Effect”), (B) there have been no
transactions entered into by the Company or any of its
subsidiaries, other than those in the ordinary course of business
or as described in the Prospectus, which are material with respect
to the Company and its subsidiaries considered as one enterprise,
and (C) except for quarterly dividends on the Common Stock in
amounts per share that are consistent with past practice, there has
been no dividend or distribution of any kind declared, paid or made
by the Company on any class of its capital stock, otherwise than as
set forth or contemplated in the Registration Statement and the
Prospectus;
(x) The
Company and its subsidiaries have good and marketable title in fee
simple to all real property and good and marketable title to all
personal property owned by them, in each case free and clear of all
mortgages, pledges, security interests, claims, restrictions,
liens, encumbrances and defects except such as are described in the
Registration Statement and the Prospectus or such as do not
materially affect the value of such property and do not interfere
with the use made and proposed to be made of such property by the
Company and its subsidiaries; and any real property and buildings
held under lease by the Company and its subsidiaries are held by
them under valid, subsisting and enforceable leases with such
exceptions as are not material and do not interfere with the use
made and proposed to be made of such property and buildings by the
Company and its subsidiaries, and neither the Company nor any
Subsidiary has any written, or to the Company’s knowledge,
oral notice of any material claim of any sort that has been
asserted by anyone adverse to the rights of the Company or any
subsidiary under any of the leases or subleases mentioned above, or
affecting or questioning the rights of the Company or such
Subsidiary to the continued possession of the leased or subleased
premises under any such lease or sublease.
(xi) The
Company is a registered bank holding company under the Bank Holding
Company Act of 1956, as amended (“BHCA”) with respect
to Bank of Smithtown (the “Bank”) and has been duly
incorporated and is validly existing as a corporation under the
laws of the jurisdiction of its incorporation, with the corporate
power and authority to own, lease and operate its properties and to
conduct its business as described in the Registration Statement and
the Prospectus and to enter into and perform its obligations under
this Agreement; the Company is duly qualified as a foreign
corporation to transact business and is in good standing in each
other jurisdiction in which such qualification is required, whether
by reason of the ownership or leasing of property or the conduct of
business, except where the failure to so qualify or to be in good
standing would not reasonably be expected to result in a Material
Adverse Effect;
(xii) Each
subsidiary of the Company has been duly incorporated and is validly
existing as a corporation, limited liability company, trust
company, statutory business trust or bank in good standing (where
applicable) under the laws of the jurisdiction of its incorporation
and has the corporate power and authority to own, lease and operate
its properties and to conduct its business as described in the
Registration Statement and the Prospectus; each subsidiary of the
Company is duly qualified as a foreign corporation to transact
business and is in good standing in each other jurisdiction in
which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except
for such jurisdictions where the failure to so qualify, or be in
good standing, would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect; all
of the issued and outstanding capital stock of each subsidiary has
been duly authorized and validly issued, is fully paid and
nonassessable and is owned by the Company, directly or through
subsidiaries; the Company owns, directly or through subsidiaries,
the issued and outstanding capital stock of each subsidiary free
and clear of any security interest, mortgage, pledge, lien,
encumbrance or claim; the Company does not own or control, directly
or indirectly, any corporation, association or other entity other
than the subsidiaries listed in Exhibit 21 to the Company’s
Annual Report on Form 10-K for the fiscal year ended December 31,
2008; none of the outstanding shares of capital stock or other
equity interest of any subsidiary was issued in violation of the
preemptive or similar rights of any security holder or equity
holder of such subsidiary; the activities of the subsidiaries of
the Bank are permitted to subsidiaries of a New York chartered
commercial bank and the deposit accounts of the Bank are insured up
to the applicable limits by the Federal Deposit Insurance
Corporation (the “FDIC”);
(xiii) The
Company has an authorized capitalization as set forth in the
Prospectus under the heading “Capitalization,” and all
of the issued shares of capital stock of the Company have been duly
and validly authorized and issued, are fully paid and
non-assessable and have been issued in compliance with applicable
federal and state securities laws; none of the outstanding shares
of Stock were issued in violation of any preemptive rights, rights
of first refusal or other similar rights to subscribe for or
purchase securities of the Company; the description of the
Company’s stock plans or arrangements and the awards granted
thereunder, set forth or incorporated by reference in the
Prospectus, accurately and fairly presents, in all material
respects, the information required to be shown with respect to such
plans and arrangements;
(xiv) The
unissued Shares to be issued and sold by the Company to the
Underwriter hereunder have been duly and validly authorized and,
when issued and delivered against payment therefor as provided
herein, will be duly and validly issued and fully paid and
non-assessable and will conform to the description of the Stock
contained in the Registration Statement and the Prospectus and the
issuance of the shares is not subject to the preemptive or other
similar rights of any security holder of the Company;
(xv) Except
as described in the Registration Statement and the Prospectus, (A)
there are no outstanding rights (contractual or otherwise),
warrants or options to acquire, or instruments convertible into or
exchangeable for, or agreements or understandings with respect to
the sale or issuance of, any shares of capital stock of or other
equity interest in the Company; and (B) there are no contracts,
agreements or understandings between the Company and any person
granting such person the right to require the Company to file a
Registration Statement under the Act or otherwise register any
securities of the Company owned or to be owned by such
person;
(xvi) The
issue and sale of the Shares by the Company and the compliance by
the Company with all of the provisions of this Agreement and the
consummation of the transactions herein contemplated have been duly
authorized by all necessary corporate action and do not and will
not, whether with or without the giving of notice or passage of
time or both, conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default or
result in a Repayment Event (as defined below) under, any
indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject, nor will such
action result in any violation of the provisions of the certificate
of incorporation or charter (as applicable) or bylaws of the
Company or any statute or any order, rule or regulation of any
federal, state, local or foreign court or governmental agency (each
a “Governmental Entity”) or body having jurisdiction
over the Company or any of its subsidiaries or any of their
properties, except for these conflicts, breaches, violations,
defaults or Repayment Events that would not result in a Material
Adverse Effect; and no consent, approval, authorization, order,
registration or qualification of or with any such court or
governmental agency or body is required for the issue and sale of
the Shares, the performance by the Company of its obligations
hereunder or the consummation by the Company of the transactions
contemplated by this Agreement, except the registration under the
Act of the Shares and except as may be required under the rules and
regulations of the Nasdaq Global Select Market or the Financial
Industry Regulatory Authority (“FINRA”) and such
consents, approvals, authorizations, registrations or
qualifications as may be required under state securities or Blue
Sky laws in connection with the purchase and distribution of the
Shares by the Underwriter. As used herein, a
“Repayment Event” means any event or condition that
gives the holder of any note, debenture or other evidence of
indebtedness (or any person acting on such holder’s behalf)
the right to require the repurchase, redemption or repayment of all
or a portion of such indebtedness by the Company or any
subsidiary;
(xvii) Neither
the Company nor any of its subsidiaries is in violation of its
certificate of incorporation or charter (as applicable) or bylaws
or in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any indenture,
mortgage, deed of trust, loan or credit agreement, note, lease or
other agreement or instrument to which it is a party or by which it
or any of its properties may be bound or to which any of the
property or assets of the Company or any subsidiary is subject
except for such defaults that would not result in a Material
Adverse Effect;
(xviii) The
statements set forth in the Prospectus under the caption
“Description of our Common Shares,” insofar as they
purport to constitute a summary of the terms of the capital stock
of the Company, and under the caption “Underwriting,”
insofar as they purport to describe the provisions of the laws and
documents referred to therein, are accurate and
complete;
(xix)
Except as disclosed in the Registration Statement and the
Prospectus, the Company and its subsidiaries are conducting their
respective businesses in compliance in all material respects with
all federal, state, local and foreign statutes, laws, rules,
regulations, decisions, directives and orders applicable to them
(including, without limitation, all regulations and orders of, or
agreements with, the New York State Banking Department, the Federal
Reserve Board (the “FRB”) and the FDIC, the Equal
Credit Opportunity Act, the Fair Housing Act, the Community
Reinvestment Act, the Home Mortgage Disclosure Act, all other
applicable fair lending laws or other laws relating to
discrimination and the Bank Secrecy Act and Title III of the USA
Patriot Act), and neither the Company nor any of its subsidiaries
has received any written, or to the Company’s knowledge, oral
communication from any Governmental Entity asserting that the
Company or any of its subsidiaries is not in material compliance
with any statute, law, rule, regulation, decision, directive or
order;
(xx) Except
as disclosed in the Registration Statement and the Prospectus,
there are no legal or governmental actions or suits,
investigations, inquiries or proceedings before or by any court or
Government Entity, now pending or, to the knowledge of the Company,
threatened or contemplated, to which the Company or any of its
subsidiaries is a party or of which any property of the Company or
any of its subsidiaries is the subject (A) that is required to be
disclosed in the Registration Statement by the Act or by the rules
and regulations of the Commission thereunder and not disclosed
therein or (B) which, if determined adversely to the Company or any
of its subsidiaries, would, individually or in the aggregate, have
a Material Adverse Effect; all pending legal or governmental
proceedings to which the Company or any of its subsidiaries is a
party or of which any of their property is the subject, either
individually or in the aggregate, which are not described in the
Registration Statement, including ordinary routine litigation
incidental to their respective businesses, would not have a
Material Adverse Effect; and there are no contracts or documents of
the Company or any of its subsidiaries which would be required to
be described in the Registration Statement or to be filed as
exhibits thereto by the Act or by the rules and regulations of the
Commission thereunder which have not been so described and
filed;
(xxi) Each
of the Company and its subsidiaries possess all permits, licenses,
approvals, consents and other authorizations of (collectively,
“Governmental Licenses”), and has made all filings,
applications and registrations with, all Governmental Entities to
permit the Company or such subsidiary to conduct the business now
operated by the Company or its subsidiaries; the Company and its
subsidiaries are in compliance with the terms and conditions of all
such Governmental Licenses, except where the failure to so comply
would not, individually or in the aggregate, have a Material
Adverse Effect; all of the Governmental Licenses are valid and in
full force and effect, except where the invalidity of such
Governmental Licenses or the failure of such Governmental Licenses
to be in full force and effect would not, individually or in the
aggregate, have a Material Adverse Effect; and neither the Company
nor any of its subsidiaries has received any notice of proceedings
relating to the revocation or modification of any such Governmental
Licenses which, singly or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would result in a Material
Adverse Effect;
(xxii) Except
as described in the Prospectus and except as would not, singly or
in the aggregate, result in a Material Adverse Effect, (A) neither
the Company nor any of its subsidiaries is in violation in any
material respect of any federal, state or local statute, law, rule,
regulation, ordinance, code, policy or rule of common law or any
judicial or administrative interpretation thereof, including any
judicial or administrative order, consent, decree or judgment,
relating to pollution or protection of human health, the
environment (including, without limitation, ambient air, surface
water, groundwater, land surface or subsurface strata) or wildlife,
including, without limitation, laws and regulations relating to the
release or threatened release of chemicals, pollutants,
contaminants, wastes, toxic substances, hazardous substances,
petroleum or petroleum products, asbestos-containing materials or
mold (collectively, “Hazardous Materials”) or to the
manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials
(collectively, “Environmental Laws”), (B) the Company
and its subsidiaries have all material permits, authorizations and
approvals required under any applicable Environmental Laws and are
each in material compliance with their requirements, and (C) there
are no material pending, or to the Company’s knowledge,
threatened administrative, regulatory or judicial actions, suits,
demands, demand letters, claims, liens, notices of noncompliance or
violation, investigation or proceedings relating to any
Environmental Law against the Company or any of its
subsidiaries.
(xxiii) The
Company and each of its subsidiaries own or possess adequate rights
to use or can acquire on reasonable terms ownership or rights to
use all material patents, patent applications, patent rights,
licenses, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, know-how
(including trade secrets and other unpatented and/or unpatenable
property or confidential information, systems or procedures and
excluding generally commercially available “off the
shelf” software programs licensed pursuant to shrink wrap or
“click and accept” licenses) and licenses
(collectively, “Intellectual Property”) necessary for
the conduct of their respective businesses and have no reason to
believe that the conduct of their respective businesses will
conflict with, and have not received any notice of any claim of
infringement or conflict with, any such rights of others or any
facts or circumstances that would render any Intellectual Property
invalid or inadequate to protect the interest of the Company or any
of its subsidiaries therein, and which infringement or conflict (if
the subject of any unfavorable decision, ruling or finding) or
invalidity or inadequacy, singly or in the aggregate, would result
in a Material Adverse Effect;
(xxiv) No
relationship, direct or indirect, exists between or among the
Company or any of its subsidiaries on the one hand, and the
directors, officers, shareholders, customers or suppliers of the
Company or any of its subsidiaries on the other hand, which is
required to be described in the Registration Statement and the
Prospectus by the Act or by the rules and regulations of the
Commission thereunder which has not been so described;
(xxv) The
Company is not and, after giving effect to the offering and sale of
the Shares and after receipt of payment for the Shares and the
application of such proceeds as described in the Prospectus, will
not be an “investment company” or an entity
“controlled” by an “investment company”, as
such terms are defined in the Investment Company Act of 1940, as
amended (the “Investment Company Act”);
(xxvi) There
is and has been no failure on the part of the Company or any of the
Company’s directors or officers, in their capacities as such,
to comply in all material respects with any provision of the
Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith (the “Sarbanes-Oxley
Act”), including Section 402 related to loans and Sections
302 and 906 related to certifications;
(xxvii) Neither
the Company nor any of its subsidiaries, nor any affiliates of the
Company or its subsidiaries has taken and will not take, directly
or indirectly, any action designed to or that might be reasonably
expected to cause or result in stabilization or manipulation of the
price of the Stock to facilitate the sale or resale of the
Shares;
(xxiii) Neither
the Company nor any of its subsidiaries nor, to the Company’s
knowledge, any director, officer, employee or agent or other person
associated with or acting on behalf of the Company or any of its
subsidiaries has (A) used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expense
relating to political activity; (B) made any direct or indirect
unlawful payment to any foreign or domestic government official or
employee from corporate funds; (C) violated or is in violation of
any provision of the Foreign Corrupt Practices Act of 1977; or (D)
made any bribe, rebate, payoff, influence payment, kickback or
other unlawful payment;
(xxix)
The Company and each of its subsidiaries maintains a system of
internal accounting controls sufficient to provide reasonable
assurances that (A) transactions are executed in accordance with
management’s general or specific authorization; (B)
transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain
accountability for assets; (C) access to assets is permitted only
in accordance with management’s general or specific
authorization; and (D) the recorded accountability for assets is
compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any
differences. Since the end of the Company’s most
recent audited fiscal year, there has been (x) no material weakness
in the Company’s internal control over financial reporting
(whether or not remediated) and (y) no change in the
Company’s internal control over financial reporting that has
materially affected, or is reasonably likely to materially affect,
the Company’s internal control over financial
reporting;
(xxx)
The Company has established and maintained disclosure controls and
procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e)
under the Exchange Act), which (A) are designed to ensure that
information required to be disclosed by the Company in the reports
that it files or submits under the 1934 Act is recorded, processed,
summarized and reported within the time periods specified in the
Commission’s rules and forms and that material information
relating to the Company and its subsidiaries is made known to the
Company’s principal executive officer and principal financial
officer by others within the Company and its subsidiaries to allow
timely decisions regarding disclosure, and (B) are effective in all
material respects to perform the functions for which they were
established. Based on the evaluation of the
Company’s disclosure controls and procedures, taken as a
whole, described above, the Company is not aware of (x) any
significant deficiency in the design or operation of internal
controls which could adversely affect the Company’s ability
to record, process, summarize and report financial data or any
material weaknesses in internal controls or (y) any fraud, whether
or not material, that involves management or other employees who
have a significant role in the Company’s internal
controls. Since the most recent evaluation of the
Company’s disclosure controls and procedures described above,
there have been no significant changes in internal controls or in
other factors that could significantly affect internal
controls.
(xxxi) Neither
the Company nor any of its subsidiaries is subject or is party to,
or has received any notice or advice that any of them may become
subject or party to any investigation with respect to, any
corrective, suspension or cease-and-desist order, agreement,
memorandum of understanding, consent agreement or other regulatory
enforcement action, proceeding or order with or by, or is a party
to any commitment letter or similar undertaking to, or is subject
to any directive by, or has been a recipient of any supervisory
letter from, or has adopted any board resolutions at the request
of, any Governmental Entity charged with the supervision or
regulation of depository institutions or engaged in the insurance
of deposits (including the FDIC) or the supervision or regulation
of the Company or any of its subsidiaries that currently relates to
or restricts in any material respect their business or their
management (each, a “Regulatory Agreement”), nor has
the Company or any of its subsidiaries been advised by any such
Governmental Entity that it is considering issuing or requesting
any such Regulatory Agreement; there is no unresolved violation,
criticism or exception by any such Governmental Entity with respect
to any report or statement relating to any examinations of the
Company or any of its subsidiaries which, in the reasonable
judgment of the Company, currently results in or is expected to
result in a Material Adverse Effect;
(xxxii) Except
as separately disclosed in writing to the Underwriter, any
“employee benefit plan” (as defined under the Employee
Retirement Income Security Act of 1974, as amended, and the
regulations and published interpretations thereunder (collectively,
“ERISA”)) established or maintained by the Company, its
subsidiaries or their “ERISA Affiliates” (as defined
below) are in compliance in all material respects with ERISA;
“ERISA Affiliate” means, with respect to the Company or
a subsidiary, any member of any group of organizations described in
Section 414(b), (c), (m) or (o) of the Internal Revenue Code of
1986, as amended, and the regulations and published interpretations
thereunder (the “Code”) of which the Company or such
subsidiary is a member; no “reportable event” (as
defined under ERISA) has occurred or is reasonably expected to
occur with respect to any “employee benefit plan”
established or maintained by the Company, its subsidiaries or any
of their ERISA Affiliates; no “employee benefit plan”
established or maintained by the Company, its subsidiaries or any
of their ERISA Affiliates, if such “employee benefit
plan” were terminated, would have any “amount of
unfunded benefit liabilities” (as defined under ERISA); none
of the Company, its subsidiaries nor any of their ERISA Affiliates
has incurred or reasonably expects to incur any liability under (A)
Title IV of ERISA with respect to termination of, or withdrawal
from, any “employee benefit plan” or (B) Sections 412,
4971, 4975 or 4980B of the Code; each “employee benefit
plan” established or maintained by the Company, its
subsidiaries or any of their ERISA Affiliates that is intended to
be qualified under Section 401(a) of the Code has received a
favorable determination or approval letter from the Internal
Revenue Service regarding its qualification under such section and
nothing has occurred whether by action or failure to act, which
would cause the loss of such qualification;
(xxxiii) The
Company and its subsidiaries, taken as a whole, are insured against
such losses and risks and in such amounts as are prudent and
customary in the business in which they are engaged; and neither
the Company nor any of its subsidiaries has any reason to believe
that it will not be able to renew its existing insurance coverage
from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect; neither
the Company nor any subsidiary has been denied any insurance
coverage which it has sought or for which it has
applied;
(xxxiv) Except as
disclosed in the Registration Statement and the Prospectus, there
are no contracts, agreements or understandings between the Company
and any person that would give rise to a valid claim against the
Company, or the Underwriter, for a brokerage commission,
finder’s fee or other like payment as a result of the
transactions contemplated by this Agreement;
(xxxv) The
Company and its consolidated subsidiaries and its other
subsidiaries have filed all necessary federal, state and foreign
income and franchise tax returns or have properly requested
extensions thereof, all such tax returns are true, complete and
correct and have paid all taxes required to be paid by any of them;
the Company has made adequate charges, accruals and reserves in the
applicable financial statements referred to in S